A Phase IV Study on Safety, Tolerability and Efficacy of Dolutegravir, Lamivudine, and Tenofovir Disoproxil Fumarate in Treatment Naïve Adult Indian Patients Living with HIV-1 (Record no. 7432)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 00681nam a22001937a 4500 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 220915b |||||||| |||| 00| 0 eng d |
100 ## - MAIN ENTRY--PERSONAL NAME | |
Personal name | Vinay Kulkarni |
245 ## - TITLE STATEMENT | |
Title | A Phase IV Study on Safety, Tolerability and Efficacy of Dolutegravir, Lamivudine, and Tenofovir Disoproxil Fumarate in Treatment Naïve Adult Indian Patients Living with HIV-1 |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
Date of publication, distribution, etc | 2022 |
Name of publisher, distributor, etc | Pragmat Obs Res |
300 ## - PHYSICAL DESCRIPTION | |
Other physical details | Aug 10;13:75-84. |
505 ## - FORMATTED CONTENTS NOTE | |
Uniform Resource Identifier | <a href="DOI: 10.2147/POR.S361907">DOI: 10.2147/POR.S361907</a> |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Dermatology |
700 ## - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ameet Dravid |
700 ## - ADDED ENTRY--PERSONAL NAME | |
Personal name | Dnyanesh Morkar |
700 ## - ADDED ENTRY--PERSONAL NAME | |
Personal name | Dwijendra Prasad |
856 ## - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375976/ |
906 ## - LOCAL DATA ELEMENT F, LDF (RLIN) | |
PMID | 35975180 |
Support By | |
942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
Item type | Article |
Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Date acquired | Total Checkouts | Barcode | Date last seen | Koha item type |
---|---|---|---|---|---|---|---|---|---|---|---|
Dewey Decimal Classification | Deenanath Mangeshkar Hospital | Deenanath Mangeshkar Hospital | 09/15/2022 | A0332 | 09/15/2022 | Article |